- Filed
- May 8, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 6, 2025 | 30.98M sh |
| Short Term Investments | Q1 2025 · Mar 31, 2025 | $12.8M |
| Short Term Investments | Q1 2025 · Dec 31, 2024 | $0 |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $46.42M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $68.42M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2024 | $83.34M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $5.32M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $4.34M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $5.54M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $4.61M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $63.03M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $70.83M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $64.79M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $72.76M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 28M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $3.18K |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$4.71M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $78.88M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | −$2.13M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.18 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.18 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $4.21M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$5.02M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$6.15M |